Colchicine In Epistenocardiac Pericarditis.

Q4 Medicine Connecticut Medicine Pub Date : 2016-10-01
Lovely Chhabra, N Gurukripa Kowlgi, David H Spodick
{"title":"Colchicine In Epistenocardiac Pericarditis.","authors":"Lovely Chhabra,&nbsp;N Gurukripa Kowlgi,&nbsp;David H Spodick","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Epistenocardiac pericarditis (EP) is a rare form of pericarditis which occurs in the early period after a myocardial infarction (MI) and is commonly regionalized to the area of infarction. The preferred treatment for EP is high-dose oral aspirin, given the compelling indication for aspirin use in the post-MI setting; however, high-dose aspirin use may be prohibitive in certain clinical situations such as with concomitant use of newer antiplatelet agents like ticagrelor. The treatment option with colchicine remains an alternative; however the efficacy of colchicine in EP is not well established. We herewith describe a case series of 11 patients with EP who were treated with colchicine.</p>","PeriodicalId":35577,"journal":{"name":"Connecticut Medicine","volume":"80 9","pages":"549-551"},"PeriodicalIF":0.0000,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Connecticut Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Epistenocardiac pericarditis (EP) is a rare form of pericarditis which occurs in the early period after a myocardial infarction (MI) and is commonly regionalized to the area of infarction. The preferred treatment for EP is high-dose oral aspirin, given the compelling indication for aspirin use in the post-MI setting; however, high-dose aspirin use may be prohibitive in certain clinical situations such as with concomitant use of newer antiplatelet agents like ticagrelor. The treatment option with colchicine remains an alternative; however the efficacy of colchicine in EP is not well established. We herewith describe a case series of 11 patients with EP who were treated with colchicine.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
秋水仙碱在心包炎中的作用。
心包炎是一种罕见的心包炎,发生在心肌梗死(MI)后的早期,通常局限于梗死区域。考虑到心肌梗死后使用阿司匹林的迫切适应症,EP的首选治疗是大剂量口服阿司匹林;然而,在某些临床情况下,如同时使用较新的抗血小板药物如替格瑞洛,大剂量阿司匹林的使用可能是禁止的。秋水仙碱仍然是一种治疗选择;然而秋水仙碱对EP的疗效尚未得到很好的证实。我们在此描述了11例接受秋水仙碱治疗的EP患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Connecticut Medicine
Connecticut Medicine Medicine-Medicine (all)
自引率
0.00%
发文量
0
期刊介绍: The Connecticut State Medical Society (CSMS) is a federation of eight component county medical associations, with a total membership exceeding 7,000 physicians. CSMS itself is a constituent state entity of the American Medical Association. Founded by the physician-patriots of the American Revolution, the Society operates from a heritage of democratic principles embodied in its Charter and Bylaws. The base of all authority in CSMS is, of course, the individual physician member. It is the decisions of members in their own county associations that ultimately determine the nature of the Society"s policies and activities.
期刊最新文献
Re: Assisted dying. Aid in Dying 6. THE MORE THINGS CHANGE, THE MORE THEY REMAIN THE SAME? The times they are A-changin'. The national cancer program.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1